Huhn Stephen L.

Huhn Stephen L. is listed in public filings as officer: CMO & Sr VP, Clinical Dev.. This Huhn Stephen L. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Contineum Therapeutics, Inc. Class A Common Stock (CTNM). Investors use Huhn Stephen L.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.